About Us

Histogen Corporate
Factsheet
Home > About Histogen > News and Events

Latest News
Histogen Wins Motion for Summary Judgment in Patent Case, Defeating SkinMedica's
Claims

Histogen Wins Patent Ruling

David Nassif Joins Histogen as President and CFO

Hypoxia Induces Multipotency in Skin Cells, Proteins Produced Trigger Cancer Stem Cell Death

More >>  


Upcoming Events

New York Stem Cell Summit
February 21, 2012
New York, NY
Dr. Gail Naughton to present Histogen

American Association for Cancer Research (AACR) Annual Meeting
March 31 - April 4, 2012
Chicago, IL
Emmett Pinney to present "A Secreted Tissue Engineered Extracellular Matrix Prevents Recurrence in Post-Resection Pancreatic Cancer Models"

Histogen's proprietary tissue-engineering process is utilized for manufacturing all of Histogen's products. Newborn cells are placed into a bioreactor and conditioned with a liquid media.
  • HSC's components have recently been shown to be critical for new hair follicle formation
  • The field of stem cell research is rapidly expanding
  • Histogen scientists have developed regenerative medical technologies without the use of stem cells or animal serum
© Histogen Inc., CA 92121